論文

査読有り
2011年6月

Tertiary Hyperparathyroidism Resistant to Cinacalcet Treatment

THERAPEUTIC APHERESIS AND DIALYSIS
  • Manabu Okada
  • Yoshihiro Tominaga
  • Kumiko Izumi
  • Hironobu Nobata
  • Takayuki Yamamoto
  • Takahisa Hiramitsu
  • Makoto Tsujita
  • Norihiko Goto
  • Koji Nanmoku
  • Toshihiko Watarai
  • Kazuharu Uchida
  • 全て表示

15
開始ページ
33
終了ページ
37
記述言語
英語
掲載種別
研究論文(学術雑誌)
DOI
10.1111/j.1744-9987.2011.00924.x
出版者・発行元
WILEY-BLACKWELL

Cinacalcet hydrochloride (cinacalcet) has been reported to be efficacious for patients with tertiary hyperparathyroidism (THPT). We experienced five patients with THPT requiring parathyroidectomy (PTx) because of resistance to cinacalcet treatment and investigated their clinical characteristics and clinical course. The maximum diameter of the parathyroid gland estimated by ultrasonography before renal transplantation was evaluated. Serum total calcium, phosphorus, intact parathyroid hormone (iPTH), alkaline phosphatase (ALP), and creatinine (Cr) levels were investigated every three months after the administration of cinacalcet and at PTx. After surgery, the Cr levels were followed. In all five patients, at least one parathyroid gland had a largest diameter of more than 1 cm, and the mean diameter was 18.7 mm (range 14.9-24.1 mm). Intact PTH and ALP levels gradually increased after the initiation of cinacalcet and the Cr levels transiently increased after PTx. These findings suggest that the existence of a severely enlarged nodular hyperplastic gland is a main factor involved in resistance to cinacalcet.

リンク情報
DOI
https://doi.org/10.1111/j.1744-9987.2011.00924.x
PubMed
https://www.ncbi.nlm.nih.gov/pubmed/21595850
Web of Science
https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=JSTA_CEL&SrcApp=J_Gate_JST&DestLinkType=FullRecord&KeyUT=WOS:000292544600008&DestApp=WOS_CPL
ID情報
  • DOI : 10.1111/j.1744-9987.2011.00924.x
  • ISSN : 1744-9979
  • PubMed ID : 21595850
  • Web of Science ID : WOS:000292544600008

エクスポート
BibTeX RIS